Bladder cancer is a prevalent urinary malignancy with high global incidence and mortality. Despite advances in diagnosis and treatment, challenges persist, particularly due to high recurrence rates and unpredictable progression. Recent evidence highlights the role of urinary tract microbiota in BC initiation, progressi...
Zhaoyang Sheng, Jinpeng Zhu, Jian-Ming Sun et al.· Frontiers in Cellular and In...· 0 citations
The tumor immune microenvironment (TIME), composed of tumor cells, immune/stromal cells, cytokines, and other components, plays a central role in determining tumor immunogenicity and response to therapy. The balance between effector T/NK cells and immunosuppressive populations such as regulatory T cells (Tregs), myeloi...
Xiaoya Dong, Fengxin Cui, Lei Wang et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.